We are looking forward to seeing all of you at the ISSCR annual meeting 23-27 June in Boston, US and to delivering an exceptional annual meeting. Even as the Society is immersed in preparations for ISSCR 2020, we remain acutely aware that our members may be personally and professionally affected by COVID-19, just as so many individuals and communities are across the world.

While stem cell research shows promise for numerous diseases and conditions, there currently are no approved stem cell-based approaches for the prevention and treatment of COVID-19 infection.

The ISSCR is updating its Guidelines for Stem Cell Research and Clinical Translation to respond to recent scientific advances that include the use of pluripotent stem cell (PSC) to create models of early human embryo development.